Bristol-Myers Squibb Co - Company Profile

Powered by

All the data and insights you need on Bristol-Myers Squibb Co in one report.

  • Save hours of research time and resources with
    our up-to-date Bristol-Myers Squibb Co Strategy Report

  • Understand Bristol-Myers Squibb Co position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Bristol-Myers Squibb Co: Overview

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, immunology, cardiovascular, and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, medical professionals, hospitals and government entities. BMS provides its products in the US, Europe, and Japan. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in Princeton, New Jersey, the US.

Gain a 360-degree view of Bristol-Myers Squibb Co and make more informed decisions for your business Gain a 360-degree view of Bristol-Myers Squibb Co and make more informed decisions for your business Find out more
Headquarters United States of America

Address Route 206 And Province Line Road, Princeton, New Jersey, 08543


Telephone 1 609 2524621

No of Employees 34,100

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange BMY (NYSE)

Revenue (2022) $45.0B -2.5% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 26.8% (2022 vs 2021)

Market Cap* $98.3B

Net Profit Margin (2022) XYZ 30.1% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Bristol-Myers Squibb Co premium industry data and analytics

4,400+

Clinical Trials

Determine Bristol-Myers Squibb Co go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2,200+

Catalyst Calendar

Proactively evaluate Bristol-Myers Squibb Co’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,700+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Bristol-Myers Squibb Co’s relevant decision makers and contact details.

1,000+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

750+

Pipeline Drugs

Identify which of Bristol-Myers Squibb Co’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

280+

Marketed Drugs

Understand Bristol-Myers Squibb Co’s commercialized product portfolio to stay one step ahead of the market.

130+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

90+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Bristol-Myers Squibb Co and assess market opportunity for new entrants with patient population 8-year forecasts.

2

Investigators

Review investigator profiles and find information on trial contacts across Bristol-Myers Squibb Co, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

12+

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Bristol-Myers Squibb Co (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Bristol-Myers Squibb Co’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Cardiovascular Drugs Abecma
Diabetes Alliance Products Abraxane
Virology Drugs Azactam
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Bristol-Myers Squibb Co portfolio and identify potential areas for collaboration Understand Bristol-Myers Squibb Co portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Regulatory Approval In April, the company received approval from the European Commission for Reblozyl (luspatercept) as a treatment for adults with transfusion-dependent anaemia.
2024 Regulatory Approval In April, the company and 2seventy bio, Inc. received approval from the U.S. Food and Drug Administration for Abecma (idecabtagene vicleucel; ide-cel) to treat adult patients with myeloma.
2024 Acquisitions/Mergers/Takeovers In March, the company acquired Karuna Therapeutics Inc.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Bristol-Myers Squibb Co Johnson & Johnson Merck & Co Inc Sanofi Novartis AG
Headquarters United States of America United States of America United States of America France Switzerland
City Princeton New Brunswick Kenilworth Paris Basel
State/Province New Jersey New Jersey New Jersey Ile-de-France -
No. of Employees 34,100 131,900 72,000 87,994 76,057
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Christopher S. Boerner Ph.D. Chairman; Chief Executive Officer Executive Board 2024 -
David V. Elkins Chief Financial Officer; Executive Vice President Senior Management 2019 55
Paul von Autenried Executive Vice President; Chief Information Officer Senior Management 2019 60
Samit Hirawat, M.D. Chief Medical Officer - Global Drug Development; Head - Development; Executive Vice President Senior Management 2019 55
Pamela Fisher Vice President; Chief - Diversity and Inclusion Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Bristol-Myers Squibb Co key executives to enhance your sales strategy Gain insight into Bristol-Myers Squibb Co key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward